336 related articles for article (PubMed ID: 18026741)
1. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences.
Kato S
Acta Neuropathol; 2008 Jan; 115(1):97-114. PubMed ID: 18026741
[TBL] [Abstract][Full Text] [Related]
2. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
3. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats.
Herdewyn S; De Muynck L; Van Den Bosch L; Robberecht W; Van Damme P
Neurobiol Aging; 2013 Oct; 34(10):2302-3. PubMed ID: 23608112
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
Manfredi G; Xu Z
Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
[TBL] [Abstract][Full Text] [Related]
5. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
6. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS.
Lladó J; Haenggeli C; Pardo A; Wong V; Benson L; Coccia C; Rothstein JD; Shefner JM; Maragakis NJ
Neurobiol Dis; 2006 Jan; 21(1):110-8. PubMed ID: 16084734
[TBL] [Abstract][Full Text] [Related]
7. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
8. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophic lateral sclerosis: all roads lead to Rome.
Gonzalez de Aguilar JL; Echaniz-Laguna A; Fergani A; René F; Meininger V; Loeffler JP; Dupuis L
J Neurochem; 2007 Jun; 101(5):1153-60. PubMed ID: 17250677
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target.
Barber SC; Shaw PJ
Free Radic Biol Med; 2010 Mar; 48(5):629-41. PubMed ID: 19969067
[TBL] [Abstract][Full Text] [Related]
11. [Proximal axonal injuries as experimental models for adult motoneuron degeneration].
Watabe K
Brain Nerve; 2007 Oct; 59(10):1179-86. PubMed ID: 17969359
[TBL] [Abstract][Full Text] [Related]
12. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
[TBL] [Abstract][Full Text] [Related]
14. Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories.
Beghi E; Mennini T;
Neurol Sci; 2004 Jun; 25 Suppl 2():S41-60. PubMed ID: 15197603
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
Dupuis L; Loeffler JP
Curr Opin Pharmacol; 2009 Jun; 9(3):341-6. PubMed ID: 19386549
[TBL] [Abstract][Full Text] [Related]
16. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis.
Durand J; Amendola J; Bories C; Lamotte d'Incamps B
J Physiol Paris; 2006; 99(2-3):211-20. PubMed ID: 16448809
[TBL] [Abstract][Full Text] [Related]
17. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
19. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis.
Schütz B
Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574
[TBL] [Abstract][Full Text] [Related]
20. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
